Overcoming Downstream Bottlenecks in the Upscaling Process
Posted on November 22, 2018
Dr. Dakshesh Mehta, Associate Vice President and Head of Bioprocess Group at Biotech & Genomics division
Pradeep Pagariya, Senior Research Scientist
Wockhardt Research Center
Over the past decade, the demand for biological therapeutics, particularly monoclonal antibodies, has increased markedly. With annual demands for therapeutic antibodies reaching several metric tons, batches >100 kg of protein are becoming more common1. Technological advancement in cell culture ha...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
biological therapeutics, Downstream Bottlenecks, inline buffer preparation, monoclonal antibodies, Upscaling Process
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
